Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle birth care cuts pain and boosts satisfaction, study finds

NCT ID NCT07514195

Symptom relief Sponsor: Sakarya University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether 'mother-friendly' hospital practices—like avoiding unnecessary medical interventions and supporting natural birth—improve outcomes for mothers and babies. 281 healthy pregnant women participated. The results showed that these practices reduced labor pain and increased maternal satisfaction, with positive effects on newborn health too.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

281 people

The number who actually took part.

Started

Feb 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women receiving care at participating centers, aged 18-45 years, with singleton pregnancies at ≥37 weeks of gestation. Participants must be planning to deliver at the study hospital and provide informed consent. Women with multiple gestations, major maternal comorbidities (e.g., pre-existing diabetes, hypertension, cardiac disease), or known fetal anomalies are excluded. The study population represents a prospective cohort of patients exposed to routine mother-friendly practices in a multicenter clinical setting.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged 18-45 2. No chronic diseases 3. No acute illnesses 4. No pregnancy complications 5. Spontaneous pregnancy 6. Full-term pregnancy 7. Appropriate-for-gestational-age (AGA) infants Exclusion Criteria: 1. Individuals over 45 years of age 2. Maternal type 1 and 2 diabetes mellitus or gestational diabetes 3. Chronic hypertension 4. Preeclampsia 5. Connective tissue disease 6. Smoking during pregnancy 7. Preterm birth (gestational age \<37 weeks) 8. small-for-gestational-age infants (birth weight \< 2 SD) 9. neonatal asphyxia (APGAR score \<7 at 1 and 5 minutes) 10. malformations, chromosomal disorders, and congenital infections 11. women with signs of chorioamnionitis (fever, leukocytosis, abdominal pain, foul-smelling discharge) more than 12 hours after EMR 12. chronic kidney and liver disease 13. hematological disorders 14. Should not be administered to individuals with a pacemaker 15. Should not be administered to patients with epilepsy, transient ischemic attacks, or a history of cerebrovascular events

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delivery care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Delivery care Satisfaction with care

Contacts and locations

Locations

  • The Obstetrics Clinics of Sakarya Research and Training Hospital

    Sakarya, Adapazarı, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.